New York State Common Retirement Fund
TEVA icon

New York State Common Retirement Fund’s Teva Pharmaceuticals TEVA Stock Holding History

New York State Common Retirement Fund’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-63,741
Closed -$1.04M – 3331
2024
Q2 		$1.04M Buy
63,741
+59,781
+1,510% +$921K ﹤0.01% 1742
2024
Q1 		$55.9K Hold
3,960
– – ﹤0.01% 2951
2023
Q4 		$41.3K Sell
3,960
-228
-5% -$2.13K ﹤0.01% 3044
2023
Q3 		$42.7K Sell
4,188
-908
-18% -$8.46K ﹤0.01% 3065
2023
Q2 		$38.4K Sell
5,096
-685
-12% -$5.55K ﹤0.01% 3178
2023
Q1 		$51.2K Sell
5,781
-1,748
-23% -$17.3K ﹤0.01% 2983
2022
Q4 		$68.7K Buy
7,529
+66
+0.9% +$576 ﹤0.01% 3043
2022
Q3 		$60K Sell
7,463
-2,776
-27% -$24.5K ﹤0.01% 3108
2022
Q2 		$77K Sell
10,239
-1,854
-15% -$16.2K ﹤0.01% 3161
2022
Q1 		$114K Hold
12,093
– – ﹤0.01% 2997
2021
Q4 		$97K Hold
12,093
– – ﹤0.01% 3081
2021
Q3 		$118K Sell
12,093
-13,362
-52% -$125K ﹤0.01% 3088
2021
Q2 		$252K Buy
25,455
+13,193
+108% +$140K ﹤0.01% 2945
2021
Q1 		$142K Hold
12,262
– – ﹤0.01% 2960
2020
Q4 		$118K Buy
+12,262
New +$117K ﹤0.01% 2960
2019
Q4 		– Sell
-758,892
Closed -$5.22M – 3218
2019
Q3 		$5.22M Sell
758,892
-809,360
-52% -$6.2M 0.01% 1221
2019
Q2 		$14.5M Sell
1,568,252
-179,200
-10% -$2.16M 0.02% 821
2019
Q1 		$27.4M Buy
1,747,452
+253,600
+17% +$4.47M 0.04% 504
2018
Q4 		$23M Buy
1,493,852
+31,400
+2% +$644K 0.03% 522
2018
Q3 		$31.5M Sell
1,462,452
-17,340
-1% -$403K 0.04% 480
2018
Q2 		$36M Buy
1,479,792
+140,500
+10% +$2.87M 0.04% 416
2018
Q1 		$22.9M Buy
1,339,292
+220,600
+20% +$4.31M 0.03% 607
2017
Q4 		$21.2M Buy
1,118,692
+338,400
+43% +$5.09M 0.03% 662
2017
Q3 		$13.7M Buy
780,292
+100,200
+15% +$2.25M 0.02% 827
2017
Q2 		$22.6M Buy
680,092
+86,371
+15% +$2.67M 0.03% 582
2017
Q1 		$19.1M Buy
593,721
+1
+0% +$34 0.03% 657
2016
Q4 		$21.5M Buy
593,720
+74,401
+14% +$2.97M 0.03% 589
2016
Q3 		$23.9M Sell
519,319
-55,283
-10% -$2.88M 0.03% 528
2016
Q2 		$28.9M Hold
574,602
– – 0.04% 462
2016
Q1 		$30.7M Sell
574,602
-73,418
-11% -$4.31M 0.05% 416
2015
Q4 		$42.5M Sell
648,020
-224,482
-26% -$13.9M 0.07% 300
2015
Q3 		$49.3M Sell
872,502
-284,369
-25% -$18.4M 0.08% 254
2015
Q2 		$68.4M Sell
1,156,871
-121,323
-9% -$7.48M 0.1% 198
2015
Q1 		$79.6M Buy
1,278,194
+24,961
+2% +$1.45M 0.12% 185
2014
Q4 		$72.1M Sell
1,253,233
-171,800
-12% -$9.57M 0.11% 204
2014
Q3 		$76.6M Sell
1,425,033
-72,000
-5% -$3.81M 0.11% 186
2014
Q2 		$78.5M Buy
1,497,033
+304,474
+26% +$15.6M 0.12% 186
2014
Q1 		$63M Sell
1,192,559
-277,020
-19% -$12.8M 0.1% 212
2013
Q4 		$58.9M Buy
1,469,579
+395,369
+37% +$15.6M 0.09% 217
2013
Q3 		$40.6M Hold
1,074,210
– – 0.07% 329
2013
Q2 		$42.1M Buy
+1,074,210
New +$41.8M 0.07% 302

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

New York State Common Retirement Fund's TEVA Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 63,741 shares — an estimated $1.04M sold.

New York State Common Retirement Fund first reported a position in TEVA in Q2 2013 and held it in 41 quarters. The position peaked at $79.6M in Q1 2015. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 63,741 Teva Pharmaceuticals shares in Q3 2024, an estimated $1.04M.
  • New York State Common Retirement Fund first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 41 quarters.
  • New York State Common Retirement Fund's Teva Pharmaceuticals position peaked at $79.6M in Q1 2015.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.